Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Trials In Focus: How COVID-19 Studies Set New Standards For Collaboration, Diversity

Jan 26 2023

• By Alaric DeArment

• Source: Shutterstock

Related Content

How Little Moderna Made Big Waves In Trial Diversity

Feb 07 2022

Gene Therapy Situation Gets More Awkward With Another Death In Astellas XLMTM Study

Sep 15 2021

Deal Watch: BMS Licenses Bispecific TCR Candidate From Immatics

Dec 17 2021

For Novavax, Building Trust Was Key To Improving Diversity

Dec 14 2021

Santen Gains Ready-Made US Portfolio Via $225m Eyevance Buy

Sep 18 2020

How To Improve Diversity And Inclusion: Five Companies Share Best Practices

Apr 13 2022

Nektar Restructuring Ends Bempeg Ambitions, Cuts Staff By 70%

Apr 26 2022

Astellas To Pay $3bn For Gene Therapy Company Audentes

Dec 03 2019

Related Companies

Moderna, Inc.

Pfizer Inc.

BioNTech SE

Novavax, Inc.

Johnson & Johnson

Inhibikase Therapeutics, Inc.

Astellas Pharma, Inc.

Trefoil Therapeutics, Inc.

Santen Pharmaceutical Co., Ltd.

Theriva Biologics, Inc.

Nektar Therapeutics

Gilead Sciences, Inc.

Bristol Myers Squibb Company

Merck KGaA

Additional Topics

Clinical Trials Coronavirus COVID-19 Business Strategies Research & Development BioPharmaceutical

More from Clinical Trials

More from R&D

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window